XenoPort, Inc. (NASDAQ:XNPT)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.

Recs

0
Player Avatar riegonla (40.86) Submitted: 2/9/2010 9:53:06 PM : Outperform Start Price: $18.85 XNPT Score: -92.21

25US$ Feb 2011

Featured Broker Partners


Advertisement